Cargando…

P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre?

Detalles Bibliográficos
Autores principales:	Iqbal, N., Nadat, Z., Vessey, J.E., Martin, K.J., Brennan, A.L., Bright-Thomas, R.J., Green, H.D., Jones, A.M., Barry, P.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192150/ http://dx.doi.org/10.1016/S1569-1993(21)01167-X

Ejemplares similares

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
por: Arden, M. A., et al.
Publicado: (2021)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
por: Lumley, Elizabeth, et al.
Publicado: (2022)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection
por: Mann, Nina, et al.
Publicado: (2018)

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis
por: Schwarz, Carsten, et al.
Publicado: (2022)

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2018)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

Investigating the Temporal Relationships between Symptoms and Nebuliser Adherence in People with Cystic Fibrosis: A Series of N-of-1 Observations
por: Martin, Rosie, et al.
Publicado: (2020)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study()
por: DeNucci, Gilberto, et al.
Publicado: (2023)

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021)

Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium
por: Manunta, Maria D. I., et al.
Publicado: (2011)

Nebulisers as a potential source of airborne virus
por: Tang, Julian W., et al.
Publicado: (2020)

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study
por: Gao, Jie, et al.
Publicado: (2019)

P121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis
por: Cenk, M., et al.
Publicado: (2021)

A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
por: Smith, C., et al.
Publicado: (2023)

WS14.1 The effect of the COVID-19 pandemic on quality of life of adults with cystic fibrosis
por: Birkin, E., et al.
Publicado: (2021)

Evaluation of the genotoxicity potential and chronic inhalation toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141 b)()()
por: Millischer, R.-J., et al.
Publicado: (1995)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
por: Johler, Sarah M., et al.
Publicado: (2015)

Exploratory study of the effectiveness of nebulised saline in children with neurodisability
por: Galaz Souza, Natalia, et al.
Publicado: (2021)

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
por: Twiss, Jacob, et al.
Publicado: (2022)

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Dexmedetomidine nebulisation attenuates post-operative sore throat in patients undergoing thyroidectomy: A randomised, double-blind, comparative study with nebulised ketamine
por: Thomas, Derlin, et al.
Publicado: (2020)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
por: Alton, Eric W F W, et al.
Publicado: (2015)

Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
por: McGrath, James A., et al.
Publicado: (2019)

COPD: Will There Be Room for Nebulisers After the Current COVID-19 Pandemic?
por: Araújo, António Duarte de, et al.
Publicado: (2020)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
por: Tai, Waiting, et al.
Publicado: (2021)

An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide
por: Newton, Phillip J, et al.
Publicado: (2012)

Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial
por: Minocchieri, Stefan, et al.
Publicado: (2019)

Nebulised heparin: a new approach to the treatment of acute lung injury?
por: Suter, Peter M
Publicado: (2008)

Improvement of Pulmonary Photodynamic Therapy: Nebulisation of Curcumin-Loaded Tetraether Liposomes
por: Lehmann, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6thtfidk4jtvuap8b7oec3j6g